Natalizumab for relapsing multiple sclerosis [1]

New England Journal of Medicine

Volumn 354, Issue 22, 2006, Pages 2387-

  Tenser, Richard B ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; NATALIZUMAB; PLACEBO; MONOCLONAL ANTIBODY; VIRUS DNA; ALPHA4 INTEGRIN;

DISEASE COURSE; HUMAN; LETTER; MEDICAL LITERATURE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK FACTOR; TREATMENT RESPONSE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ISOLATION AND PURIFICATION; JC VIRUS; LEUKOENCEPHALOPATHY; MOUSE; NOTE; POLYOMA VIRUS; VIREMIA; VIROLOGY; VIRUS LOAD; CEREBROSPINAL FLUID; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; DRUG COMBINATION; IMMUNOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MICE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POLYOMAVIRUS; VIRAL LOAD; VIREMIA; DNA, VIRAL; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; INTEGRIN ALPHA4; INTERFERON-BETA;

EID: 33744501814     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc060894     Document Type: Letter

References (4)

1. Ropper AH. Selective treatment of multiple sclerosis. N Engl J Med 2006;354:965-7.
2. Polman CH, O'Connor PW, Havrdova E, et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006;354:899-910.
3. Rudick RA, Stuart WH, Calabresi PA, et al. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 2006;354:911-23.
4. Yousry TA, Major EO, Ryschkewitsch C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006;354:924-33.